Customer experience in the life science reagent market: the role of content

January 16, 2017Vizit Blog

Customer experience is emerging as a valuable and defensible differentiator for vendors in the life science reagent market. In the past, product quality and price were the two criteria that strongly determined purchase decisions. But this is no longer the case. Many vendors are already competing on price  and at the same time reacting to the increasing pressure … Read More

Extreme user profiling: good or bad for search and scientific discovery?

April 20, 2016Blog

By Andreas Persidis, CEO Biovista Inc. Are you by any chance, like me, beginning to get the feeling that when you are searching online, your digital profile may be getting in the way? That too much of this “personalized” cerebral pampering, too much of this “right information, to the right person at the right time” … Read More

Why Systematic Drug Repurposing is here to stay

February 4, 2016Blog

Why Systematic Drug Repurposing (SDR) is here to stay. The article gives 5 reasons why SDR will continue to be used as a tool for developing new therapies that are more affordable and make better use of our existing knowledge of disease pathology, drug performance and other date from the real world evidence surrounding treatments.

Survey of therapeutic strategies for chronic fatigue syndrome

February 2, 2016Announcements

Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey A new paper co-authored by Biovista and the Solve ME/CFS Initiative has just been published. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, poorly understood disorder that causes only a small number of the approximately 2.5 million Americans to receive proper diagnosis. … Read More